Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 3 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 3 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 3 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 7 hours ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 1 day ago

Please share Science & Enterprise

New Trial Testing Reformulated Covid-19 Vaccine

Panama City skyline

Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations. . . . → Read More: New Trial Testing Reformulated Covid-19 Vaccine

New Funds Backing Global Health, Early-Stage Ventures

Stock market graphic

Three new funds are financing start-up companies creating solutions for health issues in less-developed countries and early-stage life science businesses. . . . → Read More: New Funds Backing Global Health, Early-Stage Ventures

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

Cannabidiol Drug Maker Acquired in $7.2B Deal

Cannabis plant

A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal

One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

Syringe in hand

Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine. . . . → Read More: One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

Institutions Join Global Health Breakthrough Network

Networked earth

Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network

Trial Testing Multi-Company Covid-19 Therapy

SARS-Cov-2 virus

A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections. . . . → Read More: Trial Testing Multi-Company Covid-19 Therapy

Infographic – Most Americans Wearing Mask in Public

Mask wearing in USA

Wearing a face mask has become a hot-button public controversy in the U.S., but a continuing survey shows Americans by and large are wearing masks in public. . . . → Read More: Infographic – Most Americans Wearing Mask in Public

Drug Maker Gains Access to Hidden Protein Immunotherapies

T-cells and cancer cells

Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells. . . . → Read More: Drug Maker Gains Access to Hidden Protein Immunotherapies

Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Robin Shattock

A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant